Assessment demonstrates discrimination of the VACS Index 2.0 for cause-specific mortality among people with HIV on antiretroviral therapy, suggesting potential to guide targeted care.
Predicting cause-specific mortality among people with HIV (PWH) could facilitate targeted care to improve survival. We assessed discrimination of the Veterans Aging Cohort Study (VACS) Index 2.0 in predicting cause-specific mortality among PWH on antiretroviral therapy (ART).
No takes yet. Share an insight, caveat, or question.
Ambia et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: